PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 247 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,884,245 | +5.5% | 704,700 | +68.0% | 0.01% | +16.7% |
| Q2 2023 | $5,577,448 | +20.3% | 419,357 | +4.7% | 0.01% | 0.0% |
| Q1 2023 | $4,636,308 | +54.6% | 400,372 | +9.2% | 0.01% | +50.0% |
| Q4 2022 | $2,998,608 | +82.6% | 366,578 | +25.0% | 0.00% | +100.0% |
| Q3 2022 | $1,642,000 | +96.4% | 293,210 | +55.1% | 0.00% | +100.0% |
| Q2 2022 | $836,000 | -65.8% | 189,058 | -29.6% | 0.00% | -50.0% |
| Q1 2022 | $2,445,000 | -49.7% | 268,658 | +13.2% | 0.00% | -50.0% |
| Q4 2021 | $4,858,000 | -18.3% | 237,435 | +2.0% | 0.00% | -33.3% |
| Q3 2021 | $5,947,000 | -19.1% | 232,769 | +1.8% | 0.01% | -14.3% |
| Q2 2021 | $7,348,000 | -1.9% | 228,552 | +1.6% | 0.01% | -12.5% |
| Q1 2021 | $7,493,000 | +48.3% | 224,954 | +15.5% | 0.01% | +33.3% |
| Q4 2020 | $5,051,000 | +335.1% | 194,727 | +65.5% | 0.01% | +200.0% |
| Q3 2020 | $1,161,000 | – | 117,671 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WATER ISLAND CAPITAL LLC | 4,718,964 | $24,255,000 | 1.69% |
| HighVista Strategies LLC | 378,479 | $1,945,000 | 1.48% |
| Exane Asset Management | 198,743 | $1,021,539,000 | 1.26% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,110,666 | $5,709,000 | 1.07% |
| BOURNE LENT ASSET MANAGEMENT INC | 441,650 | $2,270,000 | 1.07% |
| Versor Investments LP | 3,148,691 | $16,184,000 | 0.82% |
| Magnetar Financial LLC | 6,919,655 | $35,567,000 | 0.74% |
| AQR Arbitrage LLC | 6,953,621 | $35,742,000 | 0.60% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 915,124 | $4,704,000 | 0.54% |
| Bellevue Group AG | 5,734,309 | $29,474,000 | 0.47% |